Substituted Pyrazolo[1,5-a]pyrimidine Compounds as TRK Kinase Inhibitors (2011)

Array Biopharma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application PCT/US2009/061519, filed Oct 21, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 8,865,698	METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS Array Biopharma, Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 9,127,013	METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a] PYRIMIDINE COMPOUNDS Array Biopharma, Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 9,447,104	METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS Array Biopharma, Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 9,676,783	Method of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds Array Biopharma, Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 10,005,783	Method of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds Array Biopharma, Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma, Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 10,047,097	Method of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds Array Biopharma Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 10,774,085	Method of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds Array Biopharma Inc. In force Term ends Oct 21, 2029 · High confidence	Array Biopharma Inc.	In force	Term ends Oct 21, 2029	Term ends Oct 21, 2029	High confidence
US 8,513,263	Substituted Pyrazolo[1,5-a]pyrimidine Compounds as TRK Kinase Inhibitors Array Biopharma, Inc. In force Term ends Dec 23, 2029 · High confidence	Array Biopharma, Inc.	In force	Term ends Dec 23, 2029	Term ends Dec 23, 2029	High confidence
US 11,267,818	Method of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds Array Biopharma Inc. Lapsed Mar 8, 2026 on the fee record Ended Mar 8, 2026 · High confidence	Array Biopharma Inc.	Lapsed Mar 8, 2026 on the fee record	Ended Mar 8, 2026	Ended Mar 8, 2026	High confidence
Application 17/591,961	Method of Treatment Using Substituted Pyrazolo[1,5-a] Pyrimidine Compounds Array Biopharma, Inc. Abandoned Abandoned Sep 20, 2022	Array Biopharma, Inc.	Abandoned	Abandoned Sep 20, 2022	not computed
2 more patents in this group · Pro

10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Pro members see all 12, including 1 expired.

Upgrade to Pro

8 of these are in force and held by Array Biopharma Inc..

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.